SCHEMBL14725327

SCHEMBL14725327

CSc1ccc(NC(=S)Nc2ccc(NS(=O)(=O)O)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.58
ALDH1A1 P00352 10/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPK1 P28482 2/20 0.52
MAPT P10636 3/20 0.46
ALOX12 P18054 1/20 0.46
HTT P42858 2/20 0.43
GAA P10253 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 2/20 0.43
NOX1 Q9Y5S8 1/20 0.43
IDH1 O75874 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA7 P43166 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14725326 0.80 ALDH1A1 (0.63) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL2235410 0.78 ALDH1A1 (0.69) IDO1ALDH1A1MEN1KMT2AMAPT
SCHEMBL2237481 0.76 CA1 (0.60) IDO1ALDH1A1CA12CA1CA2
SCHEMBL24894101 0.75 IDO1 (0.70) IDO1ALDH1A1MAPTALOX12HTT
SCHEMBL14725325 0.74 CA1 (0.50) ALDH1A1MEN1KMT2AMAPK1MAPT
SCHEMBL17913053 0.74 IDO1 (1.00) IDO1ALDH1A1MEN1KMT2AMAPT
SCHEMBL4455223 0.72 PTPRB (0.48) ALDH1A1MEN1KMT2AHTTALOX15
SCHEMBL27460196 0.72 ALDH1A1 (0.52) ALDH1A1KMT2AMAPTALOX12GAA
SCHEMBL14799102 0.71 ALDH1A1 (0.58) ALDH1A1MEN1KMT2AMAPK1MAPT
SCHEMBL17079615 0.70 ALDH1A1 (0.68) IDO1ALDH1A1MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130053392-A1 CARBONIC ANHYDRASE INHIBITORS UNIVERSITETET I OSLO (NO) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053392-A1 CARBONIC ANHYDRASE INHIBITORS CA9, CA2, CA4 IDO1 1310/4885ALDH1A1 682/4885MEN1 2899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.